Literature DB >> 10506151

The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.

J M Clemetson1, J Polgar, E Magnenat, T N Wells, K J Clemetson.   

Abstract

We have cloned the platelet collagen receptor glycoprotein (GP) VI from a human bone marrow cDNA library using rapid amplification of cDNA ends with platelet mRNA to complete the 5' end sequence. GPVI was isolated from platelets using affinity chromatography on the snake C-type lectin, convulxin, as a critical step. Internal peptide sequences were obtained, and degenerate primers were designed to amplify a fragment of the GPVI cDNA, which was then used as a probe to screen the library. Purified GPVI, as well as Fab fragments of polyclonal antibodies made against the receptor, inhibited collagen-induced platelet aggregation. The GPVI receptor cDNA has an open reading frame of 1017 base pairs coding for a protein of 339 amino acids including a putative 23-amino acid signal sequence and a 19-amino acid transmembrane domain between residues 247 and 265. GPVI belongs to the immunoglobulin superfamily, and its sequence is closely related to FcalphaR and to the natural killer receptors. Its extracellular chain has two Ig-C2-like domains formed by disulfide bridges. An arginine residue is found in position 3 of the transmembrane portion, which should permit association with Fcgamma and its immunoreceptor tyrosine-based activation motif via a salt bridge. With 51 amino acids, the cytoplasmic tail is relatively long and shows little homology to the C-terminal part of the other family members. The ability of the cloned GPVI cDNA to code for a functional platelet collagen receptor was demonstrated in the megakaryocytic cell line Dami. Dami cells transfected with GPVI cDNA mobilized intracellular Ca(2+) in response to collagen, unlike the nontransfected or mock transfected Dami cells, which do not respond to collagen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506151     DOI: 10.1074/jbc.274.41.29019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors.

Authors:  Jianwen Feng; David Garrity; Matthew E Call; Howell Moffett; Kai W Wucherpfennig
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

2.  Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.

Authors:  Nicholas Pugh; Anna M C Simpson; Peter A Smethurst; Philip G de Groot; Nicolas Raynal; Richard W Farndale
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

3.  Functional expression of IgA receptor FcalphaRI on human platelets.

Authors:  Kun Qian; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly; Jianming Wu
Journal:  J Leukoc Biol       Date:  2008-09-10       Impact factor: 4.962

4.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

5.  The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice.

Authors:  Yann Cheli; Deborah Jensen; Patrizia Marchese; David Habart; Tim Wiltshire; Michael Cooke; José A Fernandez; Jerry Ware; Zaverio M Ruggeri; Thomas J Kunicki
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

6.  Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets.

Authors:  Hong Chen; Mark L Kahn
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex.

Authors:  Hiroshi Takayama; Yoshitaka Hosaka; Kazuyuki Nakayama; Kamon Shirakawa; Katsuki Naitoh; Tomokazu Matsusue; Mikihiko Shinozaki; Motoyasu Honda; Yukiko Yatagai; Tetsushi Kawahara; Jiro Hirose; Tooru Yokoyama; Michiru Kurihara; Shoji Furusako
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 8.  Harnessing the platelet signaling network to produce an optimal hemostatic response.

Authors:  Lawrence F Brass; Maurizio Tomaiuolo; Timothy J Stalker
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-11       Impact factor: 3.722

9.  Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role.

Authors:  Alec A Schmaier; Zhiying Zou; Arunas Kazlauskas; Lori Emert-Sedlak; Karen P Fong; Keith B Neeves; Sean F Maloney; Scott L Diamond; Satya P Kunapuli; Jerry Ware; Lawrence F Brass; Thomas E Smithgall; Kalle Saksela; Mark L Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-25       Impact factor: 11.205

10.  G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.

Authors:  Jun Mori; Andrew C Pearce; Jennifer C Spalton; Beata Grygielska; Johannes A Eble; Michael G Tomlinson; Yotis A Senis; Steve P Watson
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.